Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/31/2025

Montelukast and Melatonin Co-Prescription Guidelines

Introduction to Montelukast and Melatonin

  • The National Asthma Education and Prevention Program recommends montelukast for asthma or allergic rhinitis, and its use should be confirmed according to these guidelines 1, 4
  • The American Academy of Sleep Medicine recommends against using melatonin for sleep onset or maintenance insomnia in adults due to weak evidence 2

Melatonin Dosage and Administration

  • Melatonin reduces sleep onset latency by only 9 minutes compared to placebo in chronic insomnia 2
  • The recommended starting dose of melatonin is 3mg immediate-release, taken 1.5-2 hours before bedtime 3
  • Higher doses (10mg) may cause receptor desensitization, morning headache, and morning sleepiness 3
  • The maximum recommended dose is 15mg, titrated in 3mg increments only if needed 3

Clinical Management and Monitoring

  • Inhaled corticosteroids are more effective than leukotriene modifiers, such as montelukast, for asthma control 1, 4
  • If neuropsychiatric symptoms develop, consider discontinuing montelukast first, as it has stronger evidence for causing these effects, and consider alternative asthma controller therapy 1, 4
  • Monitor for additive effects, such as new-onset or worsening parasomnias, vivid dreams, irritability, confusion, or concentration difficulties, and mood changes or increased depressive symptoms 3

Special Populations

  • Melatonin is considered safe in children ages 6 and older at weight-based dosing (0.15 mg/kg or 3-5mg depending on comorbidities) 3
  • Both medications carry increased risk in patients with pre-existing mood disorders, and alternative asthma therapy should be considered in these patients 1, 3, 4

Common Pitfalls to Avoid

  • Using melatonin for chronic insomnia rather than circadian disorders, as it has minimal benefit for primary insomnia and should not be used long-term for this indication 2
  • Starting with excessive melatonin doses, as higher doses cause more adverse effects without additional benefit 3
  • Failing to recognize montelukast as the likely culprit when neuropsychiatric symptoms develop 1, 4
  • Continuing montelukast when inhaled corticosteroids would be more appropriate, as ICS are more effective than leukotriene modifiers for asthma control 1, 4

REFERENCES

3

Lemborexant and Melatonin Combination for Insomnia Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Lower Doses of Melatonin Can Be More Effective Than Higher Doses [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025